Literature DB >> 16188792

Inflammatory chemokine expression in the peripheral blood of neonates with perinatal asphyxia and perinatal or nosocomial infections.

Spyros Fotopoulos1, Alexia Mouchtouri, Georgina Xanthou, Niki Lipsou, Eftichia Petrakou, Marietta Xanthou.   

Abstract

AIM: The inflammatory response induced by perinatal infections and asphyxia is considered to participate in neonatal brain damage. Inflammatory responses are characterized by the expression of chemokines. Although chemokine levels have been investigated in healthy newborns, their role during neonatal pathological conditions has not been studied. The aim of our study was to examine chemokine serum levels in asphyxiated and infected neonates.
METHODS: Peripheral blood samples were obtained from perinatally asphyxiated and infected neonates during the first days of life and from neonates who developed nosocomial infections. Serum levels of interleukin-8 (IL-8), interferon-gamma-inducible protein-10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha), and regulated upon activation, normal T cells expressed and secreted (RANTES) were determined.
RESULTS: In perinatally asphyxiated neonates, IL-8 levels were significantly elevated on the 1st day of life. In perinatally infected neonates, IL-8 and IP-10 levels were significantly increased on the 1st day of life, while RANTES levels were significantly lower and remained so until the 4th day. In nosocomially infected neonates, IL-8, IP-10 and MIP-1alpha levels were significantly increased on diagnosis of infection.
CONCLUSION: The neonatal immune system is able to produce chemokines for the induction of an inflammatory response during perinatal asphyxia and perinatal or nosocomial infections. Blockade of inflammatory chemokines could possibly contribute to the prevention of brain damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188792     DOI: 10.1111/j.1651-2227.2005.tb01988.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Plasma RANTES increase during the first month of life independently of the feeding mode.

Authors:  Kosmas Sarafidis; Elisavet Diamanti; Anna Taparkou; Vasiliki Tzimouli; Vasiliki Drossou-Agakidou; Florence Kanakoudi-Tsakalidou
Journal:  Eur J Pediatr       Date:  2006-11-11       Impact factor: 3.183

2.  Murine neonates are highly resistant to Yersinia enterocolitica following orogastric exposure.

Authors:  Andrea Echeverry; Kurt Schesser; Becky Adkins
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

3.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

4.  Risk factors for neonatal mortality due to birth asphyxia in southern Nepal: a prospective, community-based cohort study.

Authors:  Anne C C Lee; Luke C Mullany; James M Tielsch; Joanne Katz; Subarna K Khatry; Steven C LeClerq; Ramesh K Adhikari; Shardaram R Shrestha; Gary L Darmstadt
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

5.  Circulating beta chemokine and MMP 9 as markers of oxidative injury in extremely low birth weight infants.

Authors:  Girija Natarajan; Seetha Shankaran; Scott A McDonald; Abhik DAS; Barbara J Stoll; Rosemary D Higgins; Poul Thorsen; Kristin Skogstrand; David M Hougaard; Waldemar A Carlo
Journal:  Pediatr Res       Date:  2010-01       Impact factor: 3.756

6.  Effects of COX inhibition and LPS on formalin induced pain in the infant rat.

Authors:  Deirtra Hunter; Christina Chai; Gordon A Barr
Journal:  Dev Neurobiol       Date:  2014-09-13       Impact factor: 3.964

7.  Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy.

Authors:  Dorothea D Jenkins; Laura Grace Rollins; Jessica K Perkel; Carol L Wagner; Lakshmi P Katikaneni; W Thomas Bass; David A Kaufman; Michael J Horgan; Sheela Languani; Lawrence Givelichian; Koravangattu Sankaran; Jerome Y Yager; Renee H Martin
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-18       Impact factor: 6.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.